Press Releases from Pi Research and Media (1 total)
The dilemma of Hydroxychloroquine production -Will Indian pharma be able to over …
Indian pharma which has less than 20 players in the HCQ formulation ( tablet ) market which is working day and night to enhance supplies of HCQ tablets for its Coronavirus patients in India.
Interestingly, HCQ is no more a primary anti-malarial drug. It is mostly used globally to treat some immunological diseases like Lupus and Rheumatoid Arthritis. Indian drug formulators export 80-85 percent of the production to almost all parts…
